@article{7fa59bb4b73f4363a7d6be66bbad5c22,
title = "Ca2+ channel clustering with insulin-containing granules is disturbed in type 2 diabetes",
abstract = "Loss of first-phase insulin secretion is an early sign of developing type 2 diabetes (T2D). Ca2+ entry through voltage-gated L-type Ca2+ channels triggers exocytosis of insulin-containing granules in pancreatic βcells and is required for the postprandial spike in insulin secretion. Using high-resolution microscopy, we have identified a subset of docked insulin granules in human β cells and rat-derived clonal insulin 1 (INS1) cells for which localized Ca2+ influx triggers exocytosis with high probability and minimal latency. This immediately releasable pool (IRP) of granules, identified both structurally and functionally, was absent in β cells from human T2D donors and in INS1 cells cultured in fatty acids that mimic the diabetic state. Upon arrival at the plasma membrane, IRP granules slowly associated with 15 to 20 L-type channels. We determined that recruitment depended on a direct interaction with the synaptic protein Munc13, because expression of the II-III loop of the channel, the C2 domain of Munc13-1, or of Munc13-1 with a mutated C2 domain all disrupted L-type channel clustering at granules and ablated fast exocytosis. Thus, rapid insulin secretion requires Munc13-mediated recruitment of L-type Ca2+ channels in close proximity to insulin granules. Loss of this organization underlies disturbed insulin secretion kinetics in T2D.",
author = "Gandasi, {Nikhil R.} and Peng Yin and Michela Riz and Chibalina, {Margarita V.} and Giuliana Cortese and Lund, {Per Eric} and Victor Matveev and Patrik Rorsman and Arthur Sherman and Pedersen, {Morten G.} and Sebastian Barg",
note = "Funding Information: We thank Jan Saras (Uppsala University, Uppsala, Sweden) for expert technical assistance and Benoit Hastoy (University of Oxford, Oxford, United Kingdom) for performing initial characterization of EGFP-CaV1.2. This work was supported by the Swedish Science Council; the Diabetes Wellness Network Sweden; the Swedish Diabetes Society; the European Foundation for the Study of Diabetes; the Swedish Brain Foundation; the Barndiabetesfonden; Excellence of Diabetes Research in Sweden (EXODIAB); and the NovoNordisk, G{\"o}ran Gustafsson, Family Ernfors, and OE&E Johanssons foundations. The work of AS was supported by the Intramural Research Program of the NIDDK, NIH. NRG was supported by the European Foundation for the Study of Diabetes (EFSD)/Lilly Programme and the Swedish Society for Medical Research. MGP received support from the University of Padova (PRAt 2012, Strategic Research Project 2012 {"}DYCENDI{"}). The work of VM was supported by USA National Science Foundation grant DMS-1517085. The work in Oxford, United Kingdom was supported by a Wellcome Trust Senior Investigator Award (WT095531/Z/11/Z, to PR). Human islets were provided through the Juvenile Diabetes Research Foundation (JDRF) award 31-2008-416 (European Consortium of Islet Transplantation [ECIT] for Basic Research Program).",
year = "2017",
month = jun,
day = "1",
doi = "10.1172/JCI88491",
language = "English (US)",
volume = "127",
pages = "2353--2364",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "6",
}